APA
Guery B., Menichetti F., Anttila V., Adomakoh N., Aguado J. M., Bisnauthsing K., Georgopali A., Goldenberg S. D., Karas A., Kazeem G., Longshaw C., Palacios-Fabrega J. A., Cornely O. A. & Vehreschild M. J. G. T. (20190212). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. : The Lancet. Infectious diseases.
Chicago
Guery Benoit, Menichetti Francesco, Anttila Veli-Jukka, Adomakoh Nicholas, Aguado Jose Maria, Bisnauthsing Karen, Georgopali Areti, Goldenberg Simon D, Karas Andreas, Kazeem Gbenga, Longshaw Chris, Palacios-Fabrega Jose Alejandro, Cornely Oliver A and Vehreschild Maria J G T. 20190212. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. : The Lancet. Infectious diseases.
Harvard
Guery B., Menichetti F., Anttila V., Adomakoh N., Aguado J. M., Bisnauthsing K., Georgopali A., Goldenberg S. D., Karas A., Kazeem G., Longshaw C., Palacios-Fabrega J. A., Cornely O. A. and Vehreschild M. J. G. T. (20190212). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. : The Lancet. Infectious diseases.
MLA
Guery Benoit, Menichetti Francesco, Anttila Veli-Jukka, Adomakoh Nicholas, Aguado Jose Maria, Bisnauthsing Karen, Georgopali Areti, Goldenberg Simon D, Karas Andreas, Kazeem Gbenga, Longshaw Chris, Palacios-Fabrega Jose Alejandro, Cornely Oliver A and Vehreschild Maria J G T. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. : The Lancet. Infectious diseases. 20190212.